Genetic and environmental risk in AD/defining genetic, polygenic and environmental risk for Alzheimer's disease consortium (GERAD/PERADES), genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates A, tau, immunity and lipid processing
Kheder et al., 2017
These reports include serious side effects such as gastrointestinal complications, pancreatitis, and severe vomiting episodes
The availability of oral formulations addresses patient preferences for non-injectable medications while the entry of additional manufacturers beyond the current duopoly is expected to improve supply availability and create pricing competition that will facilitate broader access
While these drugs can provide partial symptomatic relief, they cannot alter the progression of AD
In this article, let's take a look at the remaining nine potential heavyweight therapies together